Main Article Content



Multimodal Computed Tomography (CT) imaging with contrast-enhanced CT angiography (CTA) is frequently being used to guide the management of acute ischemic stroke. The administration of contrast media (CM) may lead to nephrotoxicity. However, little has been reported about the safety of intravenous CM exposure in acute stroke patients. This study aims to evaluate whether there is a significant change in renal function following contrast agent administration, determine the proportion of patients developing contrast-induced acute kidney injury(CI-AKI), and analyze the risk factors associated with the same.


We analysed 138 patients with acute ischemic stroke who underwent emergency CTA at our centre, followed up on the renal parameters and prospectively evaluated them for the development of CI-AKI. The patients who developed CI-AKI were analysed for specific risk factors and categorized into risk groups based on a pre-validated risk score. Univariate and multivariate logistic regression was done to identify independent predictors of CI-AKI.


CI-AKI occurred in 19 patients (13.7%). Significant (p<0.001) changes in renal parameters were observed following contrast administration irrespective of whether it satisfied the criteria for CI-AKI. Most of the patients had a low-risk score for CI-AKI. The predicted risk of CI-AKI based on the Mehran Risk Score (MRS) was similar to that observed in our study population. No patient had to be on haemodialysis. Raised baseline S.creatinine(p-value<0.03), Diabetes with microangiopathy(p-value<0.001), and systemic hypertension(p-value<0.001) were significant predictors for CI-AKI.


The development of renal sequelae is low in acute ischemic stroke patients undergoing contrast imaging. Prompt CTA, if indicated, need not be delayed in those with no history of renal impairment or without relevant risk factors. A practical reflection of this study is to be cognizant of the renal risks that an in-patient stroke population is exposed to as Intravascular depletion, infections(urinary tract infections, pneumonia), and nephrotoxic medications.


Acute Ischemic Stroke, Contrast-Induced acute Kidney Injury, Contrast-enhanced CT Angiogram, Diabetes with Microangiopathy

Article Details

How to Cite
Gayathri Shivakumar, Suresh M.K., & Naveen P.V. (2022). Prevalence of Contrast-Induced Acute Kidney Injury in Acute Ischemic Stroke Patients Undergoing Contrast-Enhanced CT Angiography at a Tertiary Care Centre. Journal of Evolution of Medical and Dental Sciences, 11(10), 815–823.


  1. Gubitz G, Sandercock P. Acute ischaemic stroke. BMJ 2000;320(7236):692-6.
  2. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019;50(12):e344-418.
  3. Lima FO, Lev MH, Levy RA, et al. Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. Am J Neuroradiol 2010;31(5):817-21.
  4. Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ 2020;368:16983.
  5. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39(5):930-6.
  6. Meinel FG, De Cecco CN, Schoepf UJ, et al. Contrast-induced acute kidney injury: definition, epidemiology, and outcome. Biomed Res Int 2014;2014:859328.
  7. de Moura ELB, Amorim FF, Huang W, et al. Contrast-induced acute kidney injury: the importance of diagnostic criteria for establishing prevalence and prognosis in the intensive care unit. Rev Bras Ter Intensiva 2017;29(3):303-9.
  8. Davenport MS, Perazella MA, Yee J, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology 2020;294(3):660-8.
  9. Sadat U. Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies. ISRN Radiol 2013;2013:496438.
  10. Sharma J, Nanda A, Jung RS, et al. Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke. J Neurointerv Surg 2013;5(6):543-5.
  11. Hossain MA, Costanzo E, Cosentino J, et al. Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention. Saudi J Kidney Dis Transpl 2018;29(1):1-9.
  12. Kulkarni N, Vora H. Contrast-induced Nephropathy. Yearbook of Vascular and Endovascular Surgery 2016. 2017:225.
  13. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008;51(3):491–503.
  14. Solomon R. Contrast-induced acute kidney injury: is there a risk after intravenous contrast? Am Soc Nephrol 2008;3(5):1242-3.
  15. Abellás-Sequeiros RA, Raposeiras-Roubín S, Abu-Assi E, et al. Mehran contrast nephropathy risk score: is it still useful 10 years later? J Cardiol 2016;67(3):262-7.
  16. Ang TE, Bivard A, Levi C, et al. Multi-Modal CT in Acute Stroke: Wait for a Serum Creatinine before Giving Intravenous Contrast? No! International Journal of Stroke 2015;10(7):1014-7.
  17. Hopyan JJ, Gladstone DJ, Mallia G, et al. Renal safety of CT angiography and perfusion imaging in the emergency evaluation of acute stroke. Am J Neuroradiol 2008;29(10):1826-30.
  18. Dittrich R, Akdeniz S, Kloska SP, et al. Low rate of contrast-induced Nephropathy after CT perfusion and CT angiography in acute stroke patients. J Neurol 2007;254(11):1491-7.
  19. Langner S, Stumpe S, Kirsch M, et al. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium. American J Neuroradiol 2008;29(8):1525-9.
  20. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 2006;354(4):379-86.
  21. Victor SM, Gnanaraj A, Deshmukh R, et al. Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention. Indian Heart J 2014;66(5):517-24.
  22. Valappil SP, Kunjukrishnapillai S, Iype M, et al. Predictors of contrast induced nephropathy and the applicability of the Mehran risk score in high risk patients undergoing coronary angioplasty—A study from a tertiary care center in South India. Indian Heart Journal 2018;70(3):399–404.
  23. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2004;44(7):1393-9.
  24. Smith WS, Roberts HC, Chuang NA, et al. Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. Am J Neuroradiol 2003;24(4):688-90.
  25. Weisbord SD, Mor MK, Resnick AL, et al. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 2008;3(5):1274-81.
  26. Caspi O, Habib M, Cohen Y, et al. Acute kidney injury after primary angioplasty: is contrast-induced nephropathy the culprit? J Am Heart Assoc 2017;6(6):e005715.
  27. Silver SA, Shah PM, Chertow GM, et al. Risk prediction models for contrast induced nephropathy: systematic review. BMJ 2015;351:h4395.
  28. Victor SM, Gnanaraj A, Kumar SV, et al. Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention. Am J Cardiol 2013;111(7):32B.
  29. Mitchell AM, Jones AE, Tumlin JA, et al. Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol 2010;5(1):4-9.